Related Experiment Video
Updated: May 24, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Causes of obesity
Suzanne M Wright1, Louis J Aronne
1Comprehensive Weight Control Program, Weill-Cornell Medical College/New York Presbyterian Hospital, 1165 York Avenue, New York, NY 10065, USA. smw2004@med.cornell.edu
Abdominal Imaging
|March 20, 2012
Summary
Obesity rates are at unprecedented levels globally, with over 68% of US adults overweight and 35% obese. This epidemic affects all demographics, with the highest weight categories seeing the most significant proportional increase.
Area of Science:
- Public Health
- Epidemiology
- Obesity Research
Background:
- Global obesity prevalence has risen dramatically over recent decades.
- Over 68% of US adults are overweight, and 35% are obese.
- Obesity rates are increasing across all demographics and in many countries worldwide.
Purpose of the Study:
- To highlight the escalating global obesity epidemic.
- To underscore the lack of full understanding regarding the causes of rising obesity.
Main Methods:
- Analysis of epidemiological data on adult weight status.
- Review of existing literature on obesity trends and contributing factors.
Main Results:
- Obesity rates have reached unprecedented levels globally.
- Significant increases in overweight (BMI > 25 kg/m²) and obese (BMI > 30 kg/m²) populations.
- Disproportionate increases observed in individuals with the highest Body Mass Index (BMI) categories (BMI > 40 kg/m²).
Conclusions:
- The rising prevalence of obesity is a critical global public health concern.
- Further research is needed to understand the multifactorial causes of the obesity epidemic.
More Related Videos
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...